Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Alexander Makarov Appointed as Professor of HR-MS at Utrecht University

Published: Wednesday, November 06, 2013
Last Updated: Wednesday, November 06, 2013
Bookmark and Share
Dr Alexander Makarov is the inventor of the Orbitrap mass analyzer, which changed the field of chemical analysis including proteomics.

The Executive Board of Utrecht University has appointed Dr. Alexander Makarov as Professor by Special Appointment of High Resolution Mass Spectrometry at the Department of Chemistry and the Bijvoet Center. Makarov is Director of Global Research for Life Sciences Mass Spectrometry at Thermo Fisher Scientific. His appointment is a further strengthening of the close research collaboration between Thermo Fisher Scientific and the Biomolecular Mass Spectrometry and Proteomics group of Prof. Albert Heck as well as a valuable strengthening in the education of Life Sciences students at the Faculty of Science.

Dr. Alexander Makarov

Physicist Alexander Makarov (1966), is the inventor of the Orbitrap mass analyzer, which changed the field of chemical analysis including proteomics, the analysis of proteins. Understanding protein function, in the context of health and disease research, is nowadays heavily reliant on proteomics. Since its introduction in 2005, Orbitrap-based mass spectrometers quickly conquered the research market and led to many breakthroughs in the field of physical, chemical and life sciences.

Bridge that connects academia and industry
The objective of the new chair is to research new applications to the analysis of large proteins and protein assemblies. This could allow detailed measurements of a range of biologically important species.

Makarov also looks forward to working closer with master and PhD students. “I hope that this appointment will become a bridge that connects academia and industry, allowing students as well as industrial scientists to reach across the divide and engage in mutual learning”. Through his appointment, students will get the opportunity to do part of their research at Thermo Fisher Scientific and learn about research in a company environment.

Bijvoet Center and Thermo Fisher Scientific
In the Bijvoet Center for Biomolecular Research, pharmacists, chemists and biologists perform research and offer a research training programme on the relation between the structure and function of biomolecules. The Center is one of the partners in Utrecht University’s Life Sciences programme, that focusses on ‘Public health, from molecule to population’.

Thermo Fisher Scientific Inc. is the world leader in serving science. It’s mission is to enable their customers to make the world healthier, cleaner and safer. With revenues of $13 billion, it has approximately 39,000 employees and serves customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. Thermo Fisher Scientific Inc. includes three premier brands, Thermo Scientific, Fisher Scientific and Unity Lab Services. 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!